Premier Fund Managers’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-58,591
Closed -$1.56M – 211
2022
Q1
$1.56M Hold
58,591
– – 0.05% 171
2021
Q4
$2.38M Sell
58,591
-88,634
-60% -$4.04M 0.08% 144
2021
Q3
$7.38M Hold
147,225
– – 0.24% 103
2021
Q2
$8.25M Sell
147,225
-37,836
-20% -$2.02M 0.28% 95
2021
Q1
$8.57M Buy
+185,061
New +$8.96M 0.33% 80

Other funds holding HCAT

Premier Fund Managers's HCAT Position: Q2 2022 in Review

Premier Fund Managers sold out of Health Catalyst (HCAT) in Q2 2022, closing a stake of 58,591 shares — an estimated $1.56M sold.

Premier Fund Managers first reported a position in HCAT in Q1 2021 and held it in 5 quarters. The position peaked at $8.57M in Q1 2021. 179 funds tracked by Wall St. Rank hold HCAT as of Q2 2022.

  • Premier Fund Managers reported no remaining Health Catalyst position as of Q2 2022 after selling out during the quarter.
  • Premier Fund Managers sold 58,591 Health Catalyst shares in Q2 2022, an estimated $1.56M.
  • Premier Fund Managers first reported a position in Health Catalyst in Q1 2021 and held it in 5 quarters.
  • Premier Fund Managers's Health Catalyst position peaked at $8.57M in Q1 2021.
  • 179 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2022.

Based on Premier Fund Managers's 13F filing for Q2 2022, filed 8 Aug 2022.